To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene WBSCR22TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
318 supporting clones for gene WBSCR22 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CR603690 neuroblastoma .a 1 to 1219 1 to 1219 exact tiling clone,   1219/1219
(100 %)
0 diff
(100 %id)
AA099700 colon, tumor .a 577 to 1008 433 to 1       433/433
(100 %)
1 diff
(99.8 %id)
BX433968 neuroblastoma .a 641 to 1219 578 to 1       578/710
(81 %)
17 diff
(97.7 %id)
AA363484 ovary .a 742 to 1070 1 to 330       330/332
(99 %)
4 diff
(98.8 %id)
T34707 ovary .a 742 to 1030 1 to 289       289/295
(97 %)
1 diff
(99.7 %id)
BF670013 brain, primitive neuroectoderm .b 1 to 696 7 to 713       674/714
(94 %)
38 diff
(94.7 %id)
AF412034   .b 1 to 1149 6 to 1154 exact tiling clone, AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 1154/1154
(100 %)
0 diff
(100 %id)
DT220127 brain .b 1 to 635 6 to 640       640/640
(100 %)
0 diff
(100 %id)
BF692950 muscle (skeletal) .b 1 to 566 6 to 567       567/849
(66 %)
15 diff
(98.3 %id)
BP280183   .b 1 to 579 6 to 584       584/584
(100 %)
6 diff
(99.0 %id)
NM_017528.2   .b 1 to 1224 6 to 1229 exact RefSeq, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 1229/1229
(100 %)
0 diff
(100 %id)
BP348234 brain .b 1 to 582 6 to 587       587/587
(100 %)
1 diff
(99.9 %id)
AK315032   .b 1 to 899 3 to 901 exact     901/901
(100 %)
0 diff
(100 %id)
DA317514 hippocampus .b 1 to 555 4 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
DB443420 testis .b 1 to 392 3 to 397       397/397
(100 %)
11 diff
(97.3 %id)
CB108990 Liver .b 1 to 482 3 to 484       484/484
(100 %)
0 diff
(100 %id)
DA810022 brain .b 1 to 555 4 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
DA010733 adrenal gland .b 1 to 577 3 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA199272 brain .b 1 to 549 3 to 552   capped   551/551
(100 %)
2 diff
(99.7 %id)
DA222572 brain .b 1 to 557 3 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA308280 hippocampus .b 1 to 583 3 to 586   capped   585/587
(99 %)
2 diff
(99.7 %id)
DA434994 tongue, tumor tissue .b 1 to 514 3 to 517   capped   516/516
(100 %)
2 diff
(99.7 %id)
DA905074   .b 1 to 514 3 to 516   capped   515/515
(100 %)
0 diff
(100 %id)
DA905086   .b 1 to 560 3 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA908132   .b 1 to 306 3 to 308   capped   307/307
(100 %)
0 diff
(100 %id)
DA110734 cerebellum .b 1 to 589 2 to 591   capped   590/590
(100 %)
2 diff
(99.7 %id)
DA894627 skeletal muscle .b 1 to 563 2 to 564   capped   563/564
(99 %)
2 diff
(99.7 %id)
BQ957390 large cell carcinoma, lung .b 4 to 756 1 to 755       755/952
(79 %)
15 diff
(98.5 %id)
DA681611 ovary .b 6 to 557 8 to 562   capped   555/555
(100 %)
4 diff
(99.3 %id)
DA893808 skeletal muscle .b 6 to 538 14 to 546   capped   533/533
(100 %)
1 diff
(99.9 %id)
BC001780 Skin, melanotic melanoma. .b 17 to 1149 1 to 1133 exact available from MGC, AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 1133/1133
(100 %)
0 diff
(100 %id)
AF420248   .b 18 to 1221 1 to 1207 exact AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 1207/1209
(99 %)
4 diff
(99.7 %id)
AH002707   .b 18 to 1221 1 to 1207 exact AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 1207/1209
(99 %)
4 diff
(99.7 %id)
AK291116   .b 25 to 979 1 to 955 exact     955/955
(100 %)
0 diff
(100 %id)
DB452299 testis .b 25 to 521 1 to 497       497/497
(100 %)
0 diff
(100 %id)
CB106743 Liver .b 25 to 517 1 to 493       493/493
(100 %)
0 diff
(100 %id)
BU602347 mixed (pool of 40 RNAs) .b 26 to 691 1 to 671       671/795
(84 %)
8 diff
(99.0 %id)
BE390452 endometrium, adenocarcinoma cell line, uterus .b 33 to 511 1 to 479       479/479
(100 %)
0 diff
(100 %id)
BC011696 Lung, small cell carcinoma .b 35 to 1224 1 to 1192 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 1192/1192
(100 %)
2 diff
(99.9 %id)
CR623572 fetal brain .b 39 to 1219 1 to 1181 exact     1181/1181
(100 %)
0 diff
(100 %id)
BX418780 brain, fetal brain .b 39 to 785 1 to 746   fully sequenced, AAA   746/746
(100 %)
2 diff
(99.8 %id)
BC000169 Cervix, carcinoma .b 40 to 1149 1 to 1110 exact available from MGC, AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 1110/1110
(100 %)
0 diff
(100 %id)
BQ956934 brain, neuroblastoma, cell line .b 43 to 961 1 to 922 G118A R238K M244N V245G R246E ...     922/922
(100 %)
10 diff
(99.0 %id)
BX358833 Placenta Cot 25-normalized .b 45 to 995 33 to 973 A2X D34X R42X L47X P236H ...     941/973
(96 %)
16 diff
(98.4 %id)
TI_1948074741   .b 48 to 233 119 to 304       186/207
(89 %)
6 diff
(97.2 %id)
CR615237 B cells (Ramos cell line) .b 52 to 1219 1 to 1168 exact     1168/1168
(100 %)
0 diff
(100 %id)
W17180 lung .b 77 to 254 1 to 178       178/178
(100 %)
2 diff
(98.9 %id)
AW178979 stomach .b 98 to 514 12 to 428       417/430
(96 %)
14 diff
(96.8 %id)
AF218007   .b 104 to 1150 1 to 1049   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 1049/1049
(100 %)
2 diff
(99.9 %id)
CV023186 mixed .b 147 to 736 1 to 590       590/590
(100 %)
0 diff
(100 %id)
BG676763 skin, squamous cell carcinoma .b 158 to 947 1 to 792       790/795
(99 %)
9 diff
(98.9 %id)
BE621527 epithelioid carcinoma, Pancreas .b 239 to 1129 890 to 9       882/1130
(78 %)
20 diff
(98.3 %id)
BI084914 epidermoid carcinoma, cell line, salivary gland .b 254 to 1102 845 to 1       845/845
(100 %)
10 diff
(98.9 %id)
CF131045 Chondrosarcoma Lung Metastasis cell lines, lung .b 261 to 979 1 to 719       719/719
(100 %)
0 diff
(100 %id)
TI_154194483   .b 261 to 1111 49 to 891       843/1027
(82 %)
14 diff
(98.7 %id)
BU197046 melanotic melanoma, cell line, skin .b 266 to 1064 33 to 832       800/977
(81 %)
20 diff
(98.0 %id)
BU179872 melanotic melanoma, cell line, skin .b 267 to 1155 1 to 893   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 893/896
(99 %)
17 diff
(98.2 %id)
BQ058497 lymph, lymphoma, cell line .b 280 to 1155 1 to 889       889/1039
(85 %)
24 diff
(97.7 %id)
BU856659 adenocarcinoma, cell line, breast .b 296 to 1111 1 to 827       827/891
(92 %)
17 diff
(98.1 %id)
BE876792 large cell carcinoma, undifferentiated, lung .b 323 to 975 1 to 652       652/653
(99 %)
4 diff
(99.4 %id)
TI_149290366   .b 336 to 1170 866 to 42       825/867
(95 %)
12 diff
(98.7 %id)
BX352291.
matches multiple genes
  .b 343 to 1219 870 to 1     also hits gene DPH5 870/938
(92 %)
14 diff
(98.6 %id)
BX435822 B cells (Ramos cell line) .b 360 to 1211 859 to 9       851/897
(94 %)
3 diff
(99.7 %id)
TI_154130162   .b 368 to 1178 861 to 58       804/1080
(74 %)
15 diff
(98.7 %id)
BQ576234 Chondrosarcoma Grade II, Left Pelvis .b 379 to 1168 789 to 1       789/789
(100 %)
4 diff
(99.5 %id)
BM794274 Ascites, stomach .b 406 to 1052 1 to 647       647/647
(100 %)
1 diff
(99.9 %id)
BQ216731 embryonal carcinoma, cell line, testis .b 414 to 983 359 to 930       572/573
(99 %)
7 diff
(98.8 %id)
TI_149313442   .b 414 to 1149 834 to 97   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 733/945
(77 %)
3 diff
(99.7 %id)
CR623973 HeLa cells Cot 25-normalized .b 415 to 1150 1 to 736   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 736/736
(100 %)
0 diff
(100 %id)
AL555506 placenta .b 415 to 1149 1 to 734   fully sequenced, AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 734/734
(100 %)
1 diff
(99.9 %id)
BE966713 melanotic melanoma, skin .b 419 to 1165 747 to 1       627/777
(80 %)
57 diff
(92.7 %id)
CB305355 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 424 to 1166 745 to 1       740/745
(99 %)
3 diff
(99.6 %id)
BU155227 melanotic melanoma, skin .b 425 to 1009 1 to 585   AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 585/585
(100 %)
0 diff
(100 %id)
TI_151704081   .b 425 to 1234 889 to 87       805/1358
(59 %)
38 diff
(97.3 %id)
BM825327 Ascites, stomach .b 468 to 1092 1 to 625       625/625
(100 %)
1 diff
(99.9 %id)
BU681818 lung .b 495 to 1166 673 to 1       673/673
(100 %)
2 diff
(99.8 %id)
BQ425353 melanotic melanoma, skin .b 499 to 1138 651 to 12     Submitted on the opposite strand 640/651
(98 %)
0 diff
(100 %id)
BQ721300 sympathetic trunk .b 499 to 1224 1 to 726       726/978
(74 %)
3 diff
(99.7 %id)
CA439449 lung, Lung Focal Fibrosis .b 505 to 1149 17 to 661   AAA Submitted on the opposite strand 645/645
(100 %)
0 diff
(100 %id)
TI_154022592   .b 514 to 1223 774 to 76   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 699/724
(96 %)
11 diff
(98.5 %id)
AA595068 Prostate, prostate tumor .b 524 to 1008 486 to 1       486/491
(98 %)
2 diff
(99.6 %id)
BQ613963 insulinoma, Pancreas .b 531 to 1149 639 to 21   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 619/619
(100 %)
1 diff
(99.9 %id)
BE386368 melanotic melanoma, skin .b 543 to 1148 1 to 607       607/607
(100 %)
7 diff
(98.9 %id)
CA771078 Pancreas, Purified pancreatic islet .b 543 to 1148 606 to 1       606/606
(100 %)
0 diff
(100 %id)
CA840933 Pancreas, Purified pancreatic islet .b 543 to 1148 606 to 1       606/606
(100 %)
2 diff
(99.7 %id)
BM509278 insulinoma, Pancreas .b 546 to 1149 625 to 22   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 604/604
(100 %)
1 diff
(99.9 %id)
BM045482 carcinoma, cell line, Prostate .b 548 to 1149 1 to 602   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 602/602
(100 %)
5 diff
(99.2 %id)
CA419122 Chondrosarcoma Grade II, Left Pelvis .b 548 to 1168 620 to 1       620/620
(100 %)
2 diff
(99.7 %id)
CA424169 cell lines, Chondrosarcoma .b 548 to 1166 618 to 1       618/618
(100 %)
2 diff
(99.7 %id)
BG280989 melanotic melanoma, skin .b 553 to 1171 1 to 619       619/886
(69 %)
11 diff
(98.8 %id)
AW392773 stomach .b 557 to 1013 27 to 486       460/500
(92 %)
7 diff
(98.6 %id)
BU069218 Pancreas, Purified pancreatic islet .b 558 to 1149 593 to 2       592/593
(99 %)
0 diff
(100 %id)
AA115398 colon, tumor .b 574 to 1155 581 to 1       581/587
(98 %)
7 diff
(98.9 %id)
AI735705 aorta .b 582 to 1148 568 to 3       566/568
(99 %)
1 diff
(99.9 %id)
AI860642 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 582 to 1149 570 to 2       569/570
(99 %)
0 diff
(100 %id)
AI885291 anaplastic oligodendroglioma, brain .b 582 to 1153 571 to 1       571/571
(100 %)
6 diff
(99.0 %id)
AW004909 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 582 to 1149 569 to 2       568/569
(99 %)
3 diff
(99.5 %id)
AI679815 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 586 to 1155 567 to 1       567/572
(99 %)
15 diff
(97.4 %id)
AI679240 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 591 to 1155 564 to 1       564/564
(100 %)
5 diff
(99.2 %id)
BQ271659 Pancreas, Purified pancreatic islet .b 591 to 1148 558 to 1       558/558
(100 %)
1 diff
(99.9 %id)
BG743638 skin .b 595 to 1002 1 to 409   AAA   409/422
(96 %)
5 diff
(98.9 %id)
CK825565 Pancreas, Purified pancreatic islet .b 606 to 1079 474 to 1     Submitted on the opposite strand 474/474
(100 %)
3 diff
(99.4 %id)
AA214094 muscle, skeletal muscle .b 608 to 1149 556 to 10       547/556
(98 %)
12 diff
(97.9 %id)
BG654433 Pancreas, Purified pancreatic islet .b 612 to 1149 539 to 3     Submitted on the opposite strand 537/539
(99 %)
0 diff
(100 %id)
AW168108 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 615 to 1154 541 to 1       541/541
(100 %)
2 diff
(99.7 %id)
AW246722 lung, small cell carcinoma .b 630 to 1160 531 to 1       531/531
(100 %)
3 diff
(99.5 %id)
BM505268 Pancreas, Purified pancreatic islet .b 631 to 1224 604 to 11   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 594/595
(99 %)
14 diff
(97.7 %id)
AA196500   .b 642 to 1155 515 to 1       515/515
(100 %)
3 diff
(99.5 %id)
CB110671 Liver .b 647 to 1058 1 to 412       412/412
(100 %)
0 diff
(100 %id)
AW874270 tumor, uterus .b 648 to 1224 585 to 11   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 575/575
(100 %)
6 diff
(99.0 %id)
AW673199 cervical carcinoma cell line, cervix .b 657 to 1149 504 to 12   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 493/493
(100 %)
2 diff
(99.6 %id)
AW194158 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 663 to 1166 505 to 1       505/505
(100 %)
3 diff
(99.5 %id)
BU598784 mixed (pool of 40 RNAs) .b 670 to 1223 1 to 563       563/824
(68 %)
14 diff
(98.4 %id)
AA305548 colon .b 686 to 1149 1 to 463       463/463
(100 %)
1 diff
(99.8 %id)
DC427153   .b 693 to 1149 456 to 1       456/545
(83 %)
1 diff
(99.9 %id)
AV738057 cord Blood .b 694 to 1130 41 to 476   AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 436/476
(91 %)
11 diff
(97.7 %id)
AA054310 colon, tumor .b 699 to 1152 461 to 1       459/463
(99 %)
14 diff
(97.0 %id)
BQ930813 sciatic nerve .b 700 to 1224 8 to 532       525/568
(92 %)
10 diff
(98.3 %id)
BM991360 lung, Metastatic Chondrosarcoma .b 701 to 1224 544 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 526/526
(100 %)
4 diff
(99.3 %id)
AI042550 senescent fibroblast .b 702 to 1155 454 to 1       454/454
(100 %)
1 diff
(99.8 %id)
F26691 pectoral muscle (after mastectomy) .b 702 to 1062 1 to 361       361/361
(100 %)
3 diff
(99.2 %id)
BM687678 eye, eye anterior segment .b 704 to 875 296 to 467   fully sequenced, AAA   172/178
(96 %)
6 diff
(96.7 %id)
BI090394 cervix .b 708 to 1166 1 to 460       460/462
(99 %)
14 diff
(97.0 %id)
AA723456 heart .b 722 to 1149 422 to 1       424/422
(100 %)
6 diff
(98.6 %id)
BX454842 brain, fetal brain .b 724 to 1211 494 to 9   fully sequenced,   486/494
(98 %)
1 diff
(99.8 %id)
AL555505 placenta .b 724 to 1095 372 to 1   fully sequenced, Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 372/372
(100 %)
7 diff
(98.2 %id)
AA662775 normal prostate, Prostate .b 726 to 1149 425 to 2       424/425
(99 %)
0 diff
(100 %id)
BM671506 eye, Retina Foveal and Macular .b 733 to 1233 519 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 501/501
(100 %)
1 diff
(99.9 %id)
AW002815 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 746 to 1149 411 to 8       404/411
(98 %)
0 diff
(100 %id)
AI978935 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 748 to 1225 484 to 7   tiling clone,   478/484
(98 %)
0 diff
(100 %id)
AI874137 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 751 to 1153 403 to 1       403/403
(100 %)
3 diff
(99.3 %id)
AI858066 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .b 752 to 1224 484 to 12   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 473/473
(100 %)
11 diff
(97.7 %id)
CX865566 embryonic stem .b 753 to 1224 501 to 30   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 472/481
(98 %)
16 diff
(96.7 %id)
AI423560 brain, glioblastoma (pooled) .b 754 to 1149 396 to 1       396/396
(100 %)
0 diff
(100 %id)
BF969740 adrenal cortex carcinoma, cell line, adrenal gland .b 755 to 1221 1 to 469       469/588
(79 %)
12 diff
(98.0 %id)
AI093074 heart .b 757 to 1149 394 to 2       393/394
(99 %)
0 diff
(100 %id)
AA401387   .b 767 to 1149 392 to 10       383/392
(97 %)
0 diff
(100 %id)
DB517861 testis .b 770 to 1224 1 to 454     Submitted on the opposite strand 454/454
(100 %)
2 diff
(99.6 %id)
DB523012 testis .b 771 to 1225 1 to 457     Submitted on the opposite strand 457/458
(99 %)
3 diff
(99.4 %id)
BX390784   .b 772 to 1224 1 to 456       456/456
(100 %)
5 diff
(99.0 %id)
DB513078 testis .b 782 to 1224 1 to 445     Submitted on the opposite strand 445/445
(100 %)
12 diff
(97.4 %id)
AA521478 germinal center B cell .b 782 to 1224 466 to 22   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 445/510
(87 %)
11 diff
(97.9 %id)
AA654117 epithelium (cell line), Prostate .b 795 to 1155 360 to 1       360/360
(100 %)
2 diff
(99.5 %id)
AA720623 germinal center B cell .b 795 to 1030 236 to 1       236/236
(100 %)
0 diff
(100 %id)
AA938588 2 pooled tumors (clear cell type), Kidney .b 795 to 1153 359 to 1       359/359
(100 %)
1 diff
(99.8 %id)
AA961375 pooled germ cell tumors .b 795 to 1152 358 to 1       358/358
(100 %)
3 diff
(99.2 %id)
AI147589 uterus .b 795 to 1149 355 to 1       355/355
(100 %)
0 diff
(100 %id)
AI569157 adenocarcinoma, Pancreas .b 795 to 1153 359 to 1       359/359
(100 %)
5 diff
(98.7 %id)
AA219490 brain, neuroepithelial cells .b 797 to 1153 356 to 1       356/357
(99 %)
2 diff
(99.5 %id)
T10602   .b 799 to 1148 350 to 1       350/351
(99 %)
3 diff
(99.2 %id)
T49608 placenta .b 799 to 1144 355 to 12       344/355
(96 %)
0 diff
(100 %id)
AA669766 lung, lung carcinoma .b 801 to 1143 344 to 1       344/344
(100 %)
1 diff
(99.8 %id)
F19213 pectoral muscle (after mastectomy) .b 802 to 1151 1 to 350       350/350
(100 %)
0 diff
(100 %id)
BG939589 bone marrow stroma .b 817 to 1169 355 to 1       355/355
(100 %)
9 diff
(97.5 %id)
BX490076   .b 818 to 1149 1 to 331   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 331/331
(100 %)
2 diff
(99.4 %id)
CR742387 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 820 to 1164 345 to 1       345/345
(100 %)
0 diff
(100 %id)
AA402197 ovarian tumor, ovary .b 820 to 991 1 to 170   fully sequenced,   170/170
(100 %)
3 diff
(98.3 %id)
BM672635 eye, eye anterior segment .b 830 to 1166 336 to 1   fully sequenced,   336/336
(100 %)
1 diff
(99.8 %id)
BP431148   .b 840 to 1225 1 to 382       382/388
(98 %)
5 diff
(98.8 %id)
R37020 whole brain .b 842 to 1149 319 to 12   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 308/320
(96 %)
3 diff
(99.1 %id)
R52626 whole brain .b 842 to 1224 404 to 15   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 390/404
(96 %)
10 diff
(97.6 %id)
AW152029 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 842 to 1154 313 to 1       313/318
(98 %)
7 diff
(97.8 %id)
AV744757 cord Blood .b 853 to 1124 1 to 259   AAA   259/264
(98 %)
17 diff
(93.6 %id)
BP421694 small intestine .b 853 to 1153 1 to 301     Submitted on the opposite strand 301/301
(100 %)
4 diff
(98.7 %id)
Z41689 brain, total brain .b 855 to 1027 173 to 1       173/173
(100 %)
0 diff
(100 %id)
AJ278593 colon .b 866 to 1150 285 to 1       285/310
(91 %)
3 diff
(99.1 %id)
BG319474 skin .b 868 to 1109 1 to 242       242/242
(100 %)
0 diff
(100 %id)
AA478382 ovarian tumor, ovary .b 869 to 1009 141 to 1   fully sequenced,   141/141
(100 %)
0 diff
(100 %id)
W24918 lung .b 875 to 1141 274 to 5     Submitted on the opposite strand 270/274
(98 %)
0 diff
(100 %id)
BE042414 colon, moderately-differentiated adenocarcinoma .b 878 to 1225 352 to 6       347/352
(98 %)
0 diff
(100 %id)
AA639469 colon, colon tumor RER+ .b 885 to 1224 338 to 1       338/338
(100 %)
4 diff
(98.9 %id)
H24451 whole brain .b 888 to 1224 367 to 18   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 350/356
(98 %)
16 diff
(95.6 %id)
AI758535 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .b 913 to 1149 244 to 8       237/246
(96 %)
0 diff
(100 %id)
AW628815 pooled .b 917 to 1148 234 to 3       232/234
(99 %)
0 diff
(100 %id)
AA813693   .b 941 to 1155 215 to 1       215/215
(100 %)
1 diff
(99.6 %id)
AA865839 Kidney .b 942 to 1152 211 to 1       211/220
(95 %)
10 diff
(95.5 %id)
AI752008 Bone, Hip .b 947 to 1203 264 to 8       257/264
(97 %)
0 diff
(100 %id)
BF475925 Prostate .b 958 to 1225 270 to 3       268/270
(99 %)
0 diff
(100 %id)
AI382264 B-cell, chronic lymphotic leukemia .b 964 to 1224 275 to 12   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 264/264
(100 %)
2 diff
(99.3 %id)
AW438948 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 968 to 1224 275 to 17   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 259/259
(100 %)
8 diff
(97.0 %id)
AA508840 colon .b 982 to 1224 253 to 11   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 243/243
(100 %)
0 diff
(100 %id)
AA503742 colon .b 985 to 1224 240 to 1       240/240
(100 %)
1 diff
(99.6 %id)
N89703 lung .b 999 to 1149 151 to 1       151/151
(100 %)
0 diff
(100 %id)
N44597 melanocyte .b 1024 to 1224 1 to 203       203/205
(99 %)
7 diff
(96.6 %id)
AI478466 Kidney .b 1025 to 1225 205 to 4       202/205
(98 %)
0 diff
(100 %id)
AI802301   .b 1097 to 1225 141 to 9       133/145
(91 %)
0 diff
(100 %id)
DA900457 skeletal muscle .c 1 to 567 3 to 569   tiling clone, capped   568/568
(100 %)
0 diff
(100 %id)
BX473240   .c 24 to 544 1 to 520       520/520
(100 %)
4 diff
(99.3 %id)
BI462788 testis .c 29 to 712 6 to 694       689/695
(99 %)
15 diff
(97.9 %id)
DB447911 testis .c 31 to 461 1 to 431       431/431
(100 %)
0 diff
(100 %id)
BG171292 hypernephroma, cell line, Kidney .c 38 to 806 1 to 767       769/838
(91 %)
25 diff
(97.1 %id)
BG329482 eye, retinoblastoma .c 40 to 793 1 to 750       750/768
(97 %)
11 diff
(98.6 %id)
BF671139 muscle (skeletal) .c 42 to 666 1 to 613       613/872
(70 %)
28 diff
(96.8 %id)
BE395855 endometrium, adenocarcinoma cell line, uterus .c 56 to 603 1 to 549       549/549
(100 %)
2 diff
(99.7 %id)
BE255316 eye, retinoblastoma .c 60 to 641 1 to 583       583/583
(100 %)
4 diff
(99.4 %id)
BE786018 large cell carcinoma, lung .c 76 to 712 1 to 636       636/636
(100 %)
5 diff
(99.3 %id)
BE258327 eye, retinoblastoma .c 78 to 744 1 to 658       658/751
(87 %)
16 diff
(97.9 %id)
BQ020554 Fibrosarcoma .c 511 to 1204 693 to 1   tiling clone,   693/699
(99 %)
2 diff
(99.8 %id)
DA896695 skeletal muscle .d 1 to 563 2 to 569   tiling clone, capped   568/568
(100 %)
6 diff
(99.0 %id)
BF203725 muscle, rhabdomyosarcoma .d 2 to 499 1 to 499       499/966
(51 %)
12 diff
(98.8 %id)
BQ961799 epithelioid carcinoma cell line, Pancreas .d 12 to 820 10 to 819       810/912
(88 %)
18 diff
(98.1 %id)
BF315088 brain, neuroblastoma .d 15 to 685 1 to 668       666/938
(71 %)
14 diff
(98.6 %id)
CR602260 Placenta Cot 25-normalized .d 29 to 1288 1 to 1260 exact tiling clone,   1260/1260
(100 %)
0 diff
(100 %id)
AL545586 placenta, Placenta Cot 25-normalized .d 29 to 617 1 to 589   fully sequenced,   589/589
(100 %)
0 diff
(100 %id)
AW630552.
matches multiple genes
2 pooled high-grade transitional celltumors, genitourinary tract .d 32 to 290 1 to 259     also hits gene HES1 259/442
(58 %)
1 diff
(99.8 %id)
AA205469   .d 33 to 584 1 to 549       549/549
(100 %)
7 diff
(98.8 %id)
BE564379 bladder, carcinoma, cell line .d 37 to 728 1 to 693       693/697
(99 %)
20 diff
(97.2 %id)
BQ231937 melanotic melanoma, skin .d 38 to 732 1 to 696       696/934
(74 %)
9 diff
(99.1 %id)
BG179661 adenocarcinoma, cell line, Prostate .d 69 to 881 1 to 807       806/807
(99 %)
31 diff
(96.2 %id)
AL545557 placenta, Placenta Cot 25-normalized .d 556 to 1288 733 to 1   fully sequenced,   733/733
(100 %)
4 diff
(99.5 %id)
AA205412   .d 728 to 1396 668 to 1   tiling clone,   669/725
(92 %)
18 diff
(97.6 %id)
BP284476 bone marrow .e 1 to 588 1 to 588   tiling clone,   588/588
(100 %)
0 diff
(100 %id)
AJ224442 whole brain .e 9 to 1803 1 to 1795 exact tiling clone, AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 1795/1795
(100 %)
3 diff
(99.9 %id)
BQ368131 placenta_normal .e 713 to 1115 11 to 411       401/411
(97 %)
6 diff
(98.6 %id)
DB062677 testis .f 1 to 534 5 to 539   capped   538/538
(100 %)
1 diff
(99.9 %id)
DB070791 testis .f 1 to 528 5 to 532   tiling clone, capped   531/531
(100 %)
0 diff
(100 %id)
DC421424 uterus .f 517 to 977 1 to 462   tiling clone,   462/462
(100 %)
1 diff
(99.8 %id)
AK091162 tongue, tumor tissue .g 1 to 2495 2 to 2496 exact tiling clone, available from FLJ,   2496/2496
(100 %)
4 diff
(99.9 %id)
AX746819   .g 1 to 2495 2 to 2496 exact     2496/2496
(100 %)
4 diff
(99.9 %id)
DA437643 tongue, tumor tissue .g 1 to 546 2 to 547   capped   546/546
(100 %)
2 diff
(99.7 %id)
DB313478 tongue, tumor tissue .g 1945 to 2495 552 to 1       552/552
(100 %)
4 diff
(99.3 %id)
AW139867   .g 2105 to 2521 434 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 417/417
(100 %)
0 diff
(100 %id)
AA496389 ovarian tumor, ovary .g 2316 to 2497 1 to 181   fully sequenced,   181/181
(100 %)
5 diff
(97.3 %id)
AA496339 ovarian tumor, ovary .g 2380 to 2495 116 to 1   fully sequenced,   116/116
(100 %)
2 diff
(98.3 %id)
BF508231   .g 2410 to 2521 129 to 18   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 112/112
(100 %)
0 diff
(100 %id)
DT215868 brain .h 1 to 599 1 to 599 exact tiling clone,   599/599
(100 %)
1 diff
(99.9 %id)
DB457535 testis .i 1 to 464 1 to 464   tiling clone,   464/464
(100 %)
2 diff
(99.6 %id)
AI797997 B-cell, chronic lymphotic leukemia .i 370 to 1178 808 to 1 K2E T4H I5Y A8G W9L ... tiling clone,   808/820
(98 %)
22 diff
(97.4 %id)
BU197223 epidermoid carcinoma, cell line, salivary gland .i 458 to 1175 16 to 732 K2E tiling clone,   717/733
(97 %)
5 diff
(99.4 %id)
DA105527 cerebellum .j 1 to 504 2 to 505 exact tiling clone, capped   504/506
(99 %)
1 diff
(99.9 %id)
AK296375 thalamus .k 1 to 1072 3 to 1074 I83T tiling clone,   1074/1074
(100 %)
1 diff
(100.0 %id)
DC335548 hippocampus .k 1 to 588 3 to 590 exact tiling clone,   590/590
(100 %)
0 diff
(100 %id)
DC342904 thalamus .k 1 to 460 3 to 464       464/464
(100 %)
3 diff
(99.4 %id)
DC416029 trachea .k 402 to 836 1 to 435       435/435
(100 %)
0 diff
(100 %id)
AW379521 head_neck .k 600 to 970 371 to 1       371/372
(99 %)
14 diff
(96.3 %id)
BE149002 head_neck .k 636 to 909 1 to 277       277/277
(100 %)
14 diff
(95.0 %id)
BQ323205 colon_est .k 693 to 1060 19 to 387       369/387
(95 %)
6 diff
(98.5 %id)
AK126224 thymus .k 721 to 4606 1 to 3886   tiling clone, available from FLJ,   3886/3886
(100 %)
6 diff
(99.9 %id)
DB136202 thymus .k 722 to 1270 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
BE149018 head_neck .k 792 to 1025 1 to 237       237/252
(94 %)
11 diff
(95.7 %id)
DA112449 cerebellum .k 877 to 1453 2 to 578   capped   577/577
(100 %)
2 diff
(99.7 %id)
BF882176 lung_tumor .k 982 to 1404 527 to 105     Submitted on the opposite strand 423/527
(80 %)
0 diff
(100 %id)
DA233472 brain .k 1130 to 1701 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DA221523 brain .k 1220 to 1749 2 to 531   capped   530/530
(100 %)
1 diff
(99.9 %id)
DB144147 thymus .k 1512 to 2038 2 to 528   tiling clone, capped   527/527
(100 %)
0 diff
(100 %id)
DA389498 thalamus .k 2201 to 2775 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
DA686166   .k 2258 to 2795 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
BY798256 eye .k 2369 to 2954 1 to 586       586/586
(100 %)
5 diff
(99.2 %id)
DB120191 thymus .k 2416 to 2967 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
DB120203 thymus .k 2416 to 2964 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
BQ375803 testis_normal .k 2446 to 2771 147 to 472       326/472
(69 %)
6 diff
(98.8 %id)
DA924729 small intestine .k 2499 to 3011 2 to 514   capped   513/513
(100 %)
1 diff
(99.9 %id)
BQ708619 Spleen .k 2570 to 3437 1 to 877       877/939
(93 %)
19 diff
(98.0 %id)
BI038104 nervous_tumor .k 2642 to 2807 1 to 166       166/185
(89 %)
1 diff
(99.5 %id)
CB104688 stomach .k 2690 to 3178 1 to 485       485/485
(100 %)
13 diff
(97.4 %id)
AW880870 ovary .k 2692 to 3222 1 to 530   tiling clone,   530/530
(100 %)
4 diff
(99.3 %id)
AW175829 breast .k 2810 to 2930 121 to 1       121/121
(100 %)
3 diff
(97.6 %id)
BF372973 prostate_tumor .k 3255 to 3503 250 to 5       246/250
(98 %)
0 diff
(100 %id)
BF341604 brain, glioblastoma with EGFR amplification .k 3281 to 4038 1 to 747       747/778
(96 %)
23 diff
(97.1 %id)
CV574272 cornea, eye .k 3294 to 3929 1 to 636   tiling clone,   636/636
(100 %)
1 diff
(99.9 %id)
BG654380 Pancreas, Purified pancreatic islet .k 3355 to 3868 1 to 514       514/514
(100 %)
1 diff
(99.9 %id)
CA774984 Pancreas, Purified pancreatic islet .k 3355 to 3933 1 to 578       578/578
(100 %)
7 diff
(98.8 %id)
CV344643 bocio_tumor .k 3419 to 3660 22 to 262       241/271
(88 %)
3 diff
(98.9 %id)
BF856437 prostate_normal .k 3630 to 4070 25 to 467       443/467
(94 %)
6 diff
(98.8 %id)
CB242251 Human Lung Epithelial cells, lung .k 3748 to 4466 737 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 719/719
(100 %)
3 diff
(99.6 %id)
BF875846 lung_tumor .k 3891 to 4302 421 to 11     Submitted on the opposite strand 411/421
(97 %)
0 diff
(100 %id)
BF436057 pooled .k 3935 to 4465 531 to 1       531/531
(100 %)
0 diff
(100 %id)
BG655742 Pancreas, Purified pancreatic islet .k 3937 to 4466 530 to 1     Submitted on the opposite strand 530/530
(100 %)
0 diff
(100 %id)
BF435157 pooled .k 3941 to 4465 525 to 1       525/525
(100 %)
0 diff
(100 %id)
DB322932   .k 4023 to 4606 584 to 1       584/584
(100 %)
2 diff
(99.7 %id)
DB345012 thymus .k 4050 to 4606 557 to 1       557/557
(100 %)
0 diff
(100 %id)
CA774735 Pancreas, Purified pancreatic islet .k 4058 to 4432 397 to 1       397/397
(100 %)
15 diff
(96.3 %id)
AA402552 ovarian tumor, ovary .k 4108 to 4606 498 to 1       498/498
(100 %)
1 diff
(99.8 %id)
H12454 placenta .k 4109 to 4466 367 to 1       367/386
(95 %)
14 diff
(96.4 %id)
BF432391 pooled .k 4122 to 4465 344 to 1       344/344
(100 %)
0 diff
(100 %id)
BF432399 brain, glioblastoma (pooled) .k 4131 to 4604 474 to 1       474/474
(100 %)
0 diff
(100 %id)
BE973763 Prostate .k 4204 to 4276 582 to 657       606/658
(92 %)
48 diff
(92.8 %id)
CN427770 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .l 1 to 633 1 to 634 exact tiling clone,   634/635
(99 %)
8 diff
(98.8 %id)
AA311765   .m 1 to 401 2 to 403 D107E E108* tiling clone,   403/403
(100 %)
3 diff
(99.3 %id)
AK309574 Kidney .n 1 to 895 1 to 895 exact tiling clone,   895/895
(100 %)
2 diff
(99.8 %id)
DC362056 Kidney .n 1 to 586 1 to 587       587/587
(100 %)
3 diff
(99.5 %id)
CA397957 eye, RPE/choroid .n 692 to 1310 1 to 619   tiling clone, Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 619/619
(100 %)
5 diff
(99.2 %id)
CA428328 Bone, Subchondral Bone .n 1335 to 2083 748 to 1   tiling clone,   748/748
(100 %)
2 diff
(99.8 %id)
BI049413 placenta_normal .n 1344 to 1689 8 to 354       347/361
(96 %)
9 diff
(97.6 %id)
CA397956 eye, RPE/choroid .n 1437 to 2066 648 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 630/630
(100 %)
1 diff
(99.9 %id)
TI_151793523   .n 1604 to 2071 98 to 573   tiling clone,   476/577
(82 %)
16 diff
(97.3 %id)
DB213440 trachea .o 1 to 571 2 to 573 exact tiling clone, capped   572/572
(100 %)
1 diff
(99.9 %id)
DB154793 thymus .p 1 to 584 2 to 586   tiling clone, capped   585/585
(100 %)
1 diff
(99.9 %id)
DB346383 thymus .p 2417 to 2963 547 to 1 exact tiling clone,   547/547
(100 %)
0 diff
(100 %id)
AI270133 esophagus, squamous cell carcinoma .q 52 to 452 401 to 1 exact tiling clone,   468/470
(99 %)
7 diff
(98.6 %id)
CA436811 Bone, Subchondral Bone .r-u 1 to 341 32 to 371 I36Y tiling clone, Submitted on the opposite strand 340/377
(90 %)
7 diff
(98.2 %id)
DB069130 testis .r-u 207 to 745 2 to 540   tiling clone, capped   539/539
(100 %)
1 diff
(99.9 %id)
AW367431 head_neck .r-u 256 to 782 1 to 526   tiling clone,   526/526
(100 %)
22 diff
(95.9 %id)
BG982845 colon_normal .r-u 261 to 746 505 to 14       492/516
(95 %)
0 diff
(100 %id)
AA161417.
matches multiple genes
  .r-u 601 to 739 139 to 1     Submitted on the opposite strand, also hits gene godawbu 139/139
(100 %)
0 diff
(100 %id)
CN276674 embryonic stem cells, DMSO-treated H9 cellline .s 1 to 738 1 to 738 exact tiling clone,   738/738
(100 %)
4 diff
(99.5 %id)
DC321030 brain .s 40 to 593 1 to 554       554/554
(100 %)
0 diff
(100 %id)
AW379645 head_neck .s 72 to 647 618 to 39       580/620
(93 %)
0 diff
(100 %id)
BE063103 breast .s 74 to 682 1 to 610       610/614
(99 %)
19 diff
(97.0 %id)
AW748746 breast .s 78 to 695 12 to 630       619/639
(96 %)
8 diff
(98.8 %id)
DC309736 cerebellum .s 92 to 628 1 to 537       537/537
(100 %)
0 diff
(100 %id)
BE148901 head_neck .s 116 to 484 1 to 370       370/389
(95 %)
8 diff
(98.0 %id)
BQ322186 colon .s 117 to 556 468 to 26       443/468
(94 %)
0 diff
(100 %id)
BE151070 head_neck .s 160 to 696 544 to 5     Submitted on the opposite strand 540/590
(91 %)
0 diff
(100 %id)
BE151292 head_neck .s 175 to 707 556 to 23     Submitted on the opposite strand 534/556
(96 %)
0 diff
(100 %id)
BE063099 breast .s 195 to 689 495 to 1     Submitted on the opposite strand 495/495
(100 %)
9 diff
(98.2 %id)
AW178984 stomach .t-u 1 to 355 8 to 363 Q5T K6E V30G A31C R50S tiling clone,   363/363
(100 %)
15 diff
(95.9 %id)
BM726761 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .t-u 159 to 537 1 to 379   tiling clone,   379/379
(100 %)
0 diff
(100 %id)
BM791416 stomach .u-u 1 to 484 1 to 484 exact tiling clone,   484/484
(100 %)
1 diff
(99.8 %id)
BM794613 stomach .u-u 1 to 470 1 to 473 exact     473/473
(100 %)
4 diff
(99.2 %id)
BM795162 stomach .u-u 1 to 398 1 to 398 exact     398/398
(100 %)
1 diff
(99.8 %id)
BF737556 bladder_tumor .va-u 1 to 268 11 to 277 V17I G30V G33R G39V D40T ... tiling clone,   267/277
(96 %)
6 diff
(97.9 %id)
AK303989 trachea Gene WBSCR22, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
AW372951 breast Gene WBSCR22, variant not shown         This clone was ignored    
AW372963 breast Gene WBSCR22, variant not shown         This clone was ignored    
BX091299 ovarian tumor, ovary Gene WBSCR22, variant not shown       AAA This clone was ignored    
DB519787 testis Gene WBSCR22, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
AA284986 ovarian tumor, ovary Gene WBSCR22, variant not shown         This clone was ignored    
AA290827 ovarian tumor, ovary Gene WBSCR22, variant not shown         This clone was ignored    
AI821527 ovarian tumor, ovary Gene WBSCR22, variant not shown         This clone was ignored    
AA405168 ovarian tumor, ovary Gene WBSCR22, variant not shown         This clone was ignored    
AA405169 ovarian tumor, ovary Gene WBSCR22, variant not shown         This clone was ignored    
AI820924 ovarian tumor, ovary Gene WBSCR22, variant not shown         This clone was ignored    
AI821675 ovarian tumor, ovary Gene WBSCR22, variant not shown         This clone was ignored    
AA496413 ovarian tumor, ovary Gene WBSCR22, variant not shown       AAA This clone was ignored    
AA455797 ovarian tumor, ovary Gene WBSCR22, variant not shown         This clone was ignored    
AA456618 ovarian tumor, ovary Gene WBSCR22, variant not shown         This clone was ignored    
AA455304 ovarian tumor, ovary Gene WBSCR22, variant not shown       fully sequenced, This clone was ignored    
AA465022 ovarian tumor, ovary Gene WBSCR22, variant not shown       fully sequenced, This clone was ignored    
AA779713   Gene WBSCR22, variant not shown         Suspected internal deletion, this clone was ignored    
BF061521 pooled Gene WBSCR22, variant not shown         This clone was ignored    
DB069525 testis Gene WBSCR22, variant not shown       capped This clone was ignored    
DC415159 trachea Gene WBSCR22, variant not shown         Submitted on the opposite strand    
BP372781 umbilical cord Gene WBSCR22, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r-u, .s, .t-u, .u-u, .va-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C